Circulating leptin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: a systematic review and a meta‐analysis

Author:

Makri Evangelia S.1ORCID,Evripidou Kleo1,Polyzos Stergios A.1ORCID

Affiliation:

1. First Laboratory of Pharmacology, School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece

Abstract

AbstractBackground and AimClinical data on the association between leptin levels and nonalcoholic fatty liver disease (NAFLD)‐related liver fibrosis are conflicting. This meta‐analysis aimed to compare circulating leptin between NAFLD patients with versus without liver fibrosis or non‐NAFLD controls.MethodsA systematic search was conducted in PubMed, Scopus, and the Cochrane Library. Fifteen studies were included, reporting data from 964 individuals (422 NAFLD patients with fibrosis, 297 NAFLD patients without fibrosis, 245 no‐NAFLD controls).ResultsLeptin standardized mean difference (SMD) was higher in NAFLD patients with fibrosis (F1–F4) than in controls (SMD: 2.27; 95% confidence interval [CI]: 0.81–3.73); however, this association did not remain robust after the exclusion of studies with morbidly obese individuals. No difference was observed in leptin SMD between NAFLD patients with fibrosis and those without fibrosis (F0), and NAFLD patients without fibrosis versus controls. Heterogeneity was high (I2: 66–98%) among studies. Meta‐regression analysis revealed a positive association of leptin SMD with homeostasis model assessment‐insulin resistance, when comparing NAFLD patients with fibrosis versus NAFLD patients without fibrosis (beta: 0.53; 95% CI: 0.04–1.03), and a negative association of leptin SMD with age, when comparing NAFLD patients with fibrosis versus controls (beta: −0.29; 95% CI: −0.53 to −0.05).ConclusionCirculating leptin was higher in NAFLD patients with liver fibrosis than non‐NAFLD controls, an association, however, attenuated after the exclusion of a study with morbidly obese individuals. Circulating leptin was not different between NAFLD patients with and without fibrosis, or NAFLD patients without fibrosis and controls.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3